1 / 3

Personalized Medicine (PM) Market

The global personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%.<br>

29947
Télécharger la présentation

Personalized Medicine (PM) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Personalized Medicine (PM) Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report Till 2022 “The global personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%.” The global Personalized Medicine (PM) Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%. Personalized medicine is a branch of medical science encompassing the unique attributes of patients, particularly the genetic design, previous treatment history, behavioural attributes and environmental factors. It enables therapeutic and preventions for emphasizing the most beneficial treatment with low side effects. Key Players: GE Healthcare Illumina Incorporated Asuragen Incorporated Cepheid Abbott Laboratories Dako A/S Exact Science Corporation Biogen Decode Genetics Inc. Exagen Diagnostics Inc. Genelex Corporation Precision Biologics Incorporated

  2. Request free sample to get complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/personalized-medicine-market/request-sample Growth Drivers: To cope up with biopharmaceutical research & development, companies such as Pfizer have introduced “precision medicine”, which is capable of delivering treatments based on disease mechanism and the capacity to target and develop therapies for patients. Personalized medicine market is driven by rise in reimbursement support & regulatory framework coupled with increase in R&D activities for next generation sequencing for genetic mapping of patients by clinicians and medical practitioners. Rise in healthcare expenditures stimulates the need for effective diagnostics for cancer and increase in prevalence of chronic ailments coupled with use of biomarkers for therapeutics is expected to bolster the market growth during the forecast period. Product segmentation for personalized medicine (PM) market includes PM diagnostics, PM therapeutics, personalized nutrition & wellness and personalized medical care. Product Outlook: PM Diagnostics oGenetic Testing oDirect-to-consumer Diagnostics oEsoteric Lab Services oEsoteric Lab Tests PM Therapeutics oPharmaceutical oGenomic Medicine oMedical Devices Personalized Medical Care oTelemedicine oHealthcare Information Technology oDiseases Management Personalized Nutrition & Wellness oRetail Nutrition oComplementary Medicine oAlternative Medicine Regional Outlook: Geographical segmentation for personalized medicine industry comprises North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the global market due to rise in government funding, healthcare enhancements and technological innovations. In addition, awareness about genetic diagnostics, genome sequencing and therapeutics is likely to contribute to the market growth in the forecast period. Asia-Pacific regions are likely to grow in the estimated period due to rise in technical advances, unmet medical needs and a mass awareness throughout the industry for infectious disease, psychiatry and CNS disorders. Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

  3. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Asia Pacific Global Headquarters Million Insights Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Phone: 91-20-65300184 Email: sales@millioninsights.com

More Related